Yoga vs. physical therapy for sarcoidosis fatigue
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study compares the benefits of yoga versus standard physical therapy for people with sarcoidosis who have lung involvement and fatigue. It aims to find which approach better helps manage symptoms and improve daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sarcoidosis (specifically stage II, III, or IV) that affects your lungs.
- You have significant fatigue (scoring 22 or higher on a fatigue test).
- You have not used any immunosuppressive drugs in the past year.
- You have not taken antidepressants in the past 6 months.
- You do not have conditions like anemia, diabetes, pregnancy, fractures, osteoporosis, or major heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether virtual group sessions can help reduce fatigue related to sarcoidosis. You'll join a supportive online group with others who have similar symptoms.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This trial studies whether a structured breathing and activity program (pulmonary rehabilitation) can help people with advanced non-small-cell lung cancer. It may help improve breathing and daily function alongside standard cancer treatment.
This trial compares two treatment durations—12 months versus 6 months—of the steroid prednisolone for people with lung sarcoidosis. It aims to see if a shorter course works just as well while reducing side effects.
This study looks at how the immune system works in people with sarcoidosis. It may help researchers find better ways to diagnose or treat the disease in the future.
This trial tests if people with stable sarcoidosis can safely lower their corticosteroid dose over time. It may help reduce side effects from long-term steroid use.
Hear when a new Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.